Professionals 861 results
Capabilities 82 results
Practice Area
Practice Area
Government Program Fraud, False Claims Act & Qui Tam Litigation
Industry
Experience 46 results
Experience
|April 10, 2024
Winston assists Eurazeo in the financing of Vulcain Ingénierie's fourth LBO
Experience
|February 27, 2024
Experience
|February 16, 2024
Winston Represented Whitsons Culinary Group in its Acquisition of Fresh Picks Café
Insights & News 3,283 results
Webinar
|May 21, 2024
Bite-Sized Insights: Legal Trends Impacting the Food & Beverage Industry
Direct Sellers Update: Regulation, Law & Policy
|May 20, 2024
|3 Min Read
Navigating the FTC’s Final Rule Banning Non-Competes: Why Direct Sellers Shouldn’t Panic
The recent FTC approval of a final rule banning non-compete agreements has sparked concern and uncertainty among direct sellers. Understandably, many are wondering how this ruling will impact their businesses and what steps they can take to protect themselves against unfair competition and misuse of their intellectual property. However, amidst the apprehension, it’s essential to remember that there are avenues for safeguarding your interests, and the FTC’s rule may not be as set in stone as it initially appears.
Client Alert
|May 17, 2024
|6 Min Read
A unique entity, the Consumer Financial Protection Bureau (CFPB) has faced court challenges to its policies and structure since its inception. But in recent years, as the CFPB has become more active and, arguably, more aggressive, it has faced increasing legal scrutiny. The swirling legal challenges against the CFPB raise questions for banks and other regulated entities regarding not only how to respond to CFPB’s rulemaking but how quickly they should act to do so. This article addresses the main litigation surrounding credit card late fees and its overlap with the recent Supreme Court case upholding the validity of the Bureau’s funding structure, and in this context provides further insight into the pace at which an entity should respond to this quasi-regulator/quasi-enforcer.
Other Results 62 results
Site Content
Law Glossary
What Exclusivity Periods Are Associated with Biosimilars?